[Form 4] Corteva, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Robert D. King, EVP, Crop Protection Business at Corteva, reported multiple equity transactions on 08/29/2025. He exercised 14,960 non-qualified options with an exercise price of $58.67 and 9,337 options at $62.29, receiving the same number of common shares. On the same date he sold 37,280 shares at a weighted average price of $74.1951, with sale prices ranging $74.17–$74.23. Following these transactions his reported beneficial ownership is 49,262.2876 shares (direct). The filing notes inclusion of 25.3808 shares from dividend reinvestment and provides option vesting/expiration details for the reported grants.

Positive

• Clear disclosure of option exercises and sales including exercise prices, share counts, and weighted average sale price
• Footnotes explain the weighted average sale price range and dividend reinvestment inclusion
• Vesting and expiration dates provided for the reported option grants

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider exercised options and sold shares in a same-day transaction mix, a routine liquidity and compensation event.

The Form 4 shows contemporaneous option exercises and a substantial sale by an executive. The exercises at $58.67 and $62.29 converted options into common shares before a delegated sale of 37,280 shares at a weighted average of $74.1951, reducing reported direct holdings to 49,262.2876 shares. The filing discloses a small dividend reinvestment of 25.3808 shares and standard vesting/expiration schedules. These actions are common for executives to realize option value and diversify; the filing does not indicate any unusual trading program or Rule 10b5-1 plan.

Corporate Governance Expert

TL;DR: Transactions reflect executive compensation realization with disclosed vesting and expiration terms; governance disclosure appears complete.

The Form 4 identifies the reporting person and relationship to the issuer and provides required footnotes clarifying the weighted average sale price range, dividend reinvestment, and vesting chronology. Option details include exercise prices, number of options, expiration dates, and post-transaction derivative holdings. The signature by power-of-attorney is included. No regulatory exceptions or omissions are noted within the form's content.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

King Robert D.

(Last) (First) (Middle)

C/O CORTEVA, INC.

9330 ZIONSVILLE ROAD

(Street)

INDIANAPOLIS IN 46268

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Corteva, Inc. [ CTVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Crop Protection Business

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/29/2025		M		14,960	A	$58.67	77,179.9068	D
Common Stock	08/29/2025		M		9,337	A	$62.29	86,516.9068	D
Common Stock	08/29/2025		S		37,280	D	$74.1951(1)	49,262.2876(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right-to-buy)	$58.67	08/29/2025		M			14,960	(3)	04/04/2032	Common Stock	14,960	$0	0	D
Non-Qualified Stock Option (right-to-buy)	$62.29	08/29/2025		M			9,337	(4)	02/28/2033	Common Stock	9,337	$0	4,669	D

Explanation of Responses:

1. The price reported represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $74.17 to $74.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

2. Includes acquisition of 25.3808 shares pursuant to dividend reinvestment.

3. The options became fully exercisable on April 4, 2025, the third anniversary of the grant date.

4. One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025, and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.

	/s/Abigail Jarrell, by power-of-attorney	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Corteva (CTVA) insider Robert D. King report on 08/29/2025?

He exercised 14,960 options at $58.67, exercised 9,337 options at $62.29, and sold 37,280 shares at a weighted average price of $74.1951.

How many shares does Robert D. King beneficially own after the reported transactions?

The filing reports 49,262.2876 shares beneficially owned (direct) following the transactions.

Did the Form 4 include any dividend reinvestment or footnote details?

Yes. The filing states inclusion of 25.3808 shares from dividend reinvestment and discloses the sale price range $74.17–$74.23 as the basis for the weighted average.

What are the exercise prices and expirations for the options reported?

Reported exercise prices are $58.67 and $62.29. The form lists expirations of 04/04/2032 and 02/28/2033 for the respective option grants.

Who signed the Form 4 on behalf of the reporting person?

The form was signed by /s/Abigail Jarrell, by power-of-attorney on 09/02/2025.